NL INDUSTRIES ANNOUNCES QUARTERLY DIVIDEND FOR THE FOURTH QUARTER OF 2024 AT $.08 PER SHARE

Click here - to use the wp menu builder

Less than 1 min.Read

November 1, 2024

Dallas, Texas, Oct. 31, 2024 (GLOBE NEWSWIRE) — NL Industries, Inc. (NYSE: NL) today announced that its board of directors has declared a quarterly dividend of eight cents ($0.08) per share on its common stock, payable on December 17, 2024 to shareholders of record at the close of business on November 29, 2024.

NL Industries, Inc. is engaged in the component products (security products and recreational marine components) and chemicals (TiO₂) businesses.

* * * * *

Investor Relations Contact

Bryan A. Hanley
Senior Vice President and Treasurer
Tel. 972-233-1700

Hot this week

Topics

Popular Categories

News RoomFeatured CompaniesVideos

Progress Completes Acquisition of ShareFile

Cognition Therapeutics Presents Poster of Participant Demographics from Phase 2 Dementia with Lewy Bodies Study at CTAD

NL INDUSTRIES ANNOUNCES QUARTERLY DIVIDEND FOR THE FOURTH QUARTER OF 2024 AT $.08 PER SHARE

Intel Says It Won’t Even Make $500M From Gaudi AI Chips In 2024 Despite Nvidia Minting Billions: CEO Gelsinger Says Uptake ‘Slower Than We...

Apple, Microsoft Need To Do More Than Just Beating Wall Street Estimates, Says Analyst: ‘AI Enthusiasm And Potential Is Not Enough”

Cancer-Focused ESSA Pharma Ends Prostate Cancer Trial Due to Insufficient Efficacy From Combination Therapy

LyondellBasell Q3 Results Miss Estimates, Signals Softer Demand And Rising Costs For Q4

JPMorgan To Pay Investors $151 Million After SEC Flags ‘Various Law Violations’

Topics

Intel Says It Won’t Even Make $500M From Gaudi AI Chips In 2024 Despite Nvidia Minting Billions: CEO Gelsinger Says Uptake ‘Slower Than We...

Apple, Microsoft Need To Do More Than Just Beating Wall Street Estimates, Says Analyst: ‘AI Enthusiasm And Potential Is Not Enough”

Cancer-Focused ESSA Pharma Ends Prostate Cancer Trial Due to Insufficient Efficacy From Combination Therapy

LyondellBasell Q3 Results Miss Estimates, Signals Softer Demand And Rising Costs For Q4

JPMorgan To Pay Investors $151 Million After SEC Flags ‘Various Law Violations’

Why Charter Communications Shares Are Trading Higher By Around 11%; Here Are 20 Stocks Moving Premarket

Popular Weight Loss Drug Wegovy Shows Encouraging Results in Liver Fibrosis Trial

K12 Announces Winners of its 2024 Photography Competition

Related Articles

Intel Says It Won’t Even Make $500M From Gaudi AI Chips In 2024 Despite Nvidia Minting Billions: CEO Gelsinger Says Uptake ‘Slower Than We...

Apple, Microsoft Need To Do More Than Just Beating Wall Street Estimates, Says Analyst: ‘AI Enthusiasm And Potential Is Not Enough”

Cancer-Focused ESSA Pharma Ends Prostate Cancer Trial Due to Insufficient Efficacy From Combination Therapy

LyondellBasell Q3 Results Miss Estimates, Signals Softer Demand And Rising Costs For Q4

JPMorgan To Pay Investors $151 Million After SEC Flags ‘Various Law Violations’

Company

Headlines

Intel Says It Won’t Even Make $500M From Gaudi AI Chips In 2024 Despite Nvidia Minting Billions: CEO Gelsinger Says Uptake ‘Slower Than We...

Apple, Microsoft Need To Do More Than Just Beating Wall Street Estimates, Says Analyst: ‘AI Enthusiasm And Potential Is Not Enough”

Cancer-Focused ESSA Pharma Ends Prostate Cancer Trial Due to Insufficient Efficacy From Combination Therapy

LyondellBasell Q3 Results Miss Estimates, Signals Softer Demand And Rising Costs For Q4

Newsletter